Ogilvy Healthworld Advertiising

THE PARTICIPANT JOURNEY

It is well documented that delays in clinical trials have huge cost implications for the pharmaceutical industry, anywhere between $800k - $5.4m per day. Achieving study enrolment targets in a timely fashion is imperative. However, global participant perceptions of clinical trials demonstrate there is a lack of awareness, knowledge and understanding creating one of the biggest challenges to study enrolment.
Recognising this, Fast4wD Ogilvy has developed recruitment and retention programmes to fully engage with participants and potential participants along the clinical trial journey. Solutions are developed for each specific study to reach out to potential participants to make them aware of the a particular clinical study, fully inform them about the study and ultimately enrol them and keep them enrolled to achieve your recruitment and retention targets.

Watch the video